SCHEMBL17540920

SCHEMBL17540920

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHCY P23526 6/20 0.74
NADK O95544 1/20 0.74
DOT1L Q8TEK3 5/20 0.74
DNMT3B Q9UBC3 3/20 0.74
CARM1 Q86X55 2/20 0.74
EHMT2 Q96KQ7 2/20 0.74
PNMT P11086 2/20 0.74
DNMT1 P26358 2/20 0.74
PRMT7 Q9NVM4 2/20 0.74
TRDMT1 O14717 1/20 0.74
PRMT5 O14744 1/20 0.74
SUV39H1 O43463 1/20 0.74
PRMT3 O60678 1/20 0.74
INMT O95050 1/20 0.74
NSD2 O96028 1/20 0.74
NNMT P40261 1/20 0.74
HNMT P50135 1/20 0.74
WDR5 P61964 1/20 0.74
KMT2A Q03164 1/20 0.74
SETDB1 Q15047 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17551937 1.00 AHCY (0.74) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL19434083 1.00 AHCY (0.74) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL17551940 0.90 DOT1L (0.81) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL19432979 0.90 DOT1L (0.81) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL18661557 0.88 DOT1L (0.79) NADKDOT1LDNMT3BCARM1EHMT2
SCHEMBL18661579 0.88 DOT1L (0.79) NADKDOT1LDNMT3BCARM1EHMT2
SCHEMBL18121993 0.88 DOT1L (0.79) NADKDOT1LDNMT3BCARM1EHMT2
SCHEMBL27092963 0.87 DOT1L (0.77) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL21243035 0.87 DOT1L (0.84) AHCYNADKDOT1LDNMT3BCARM1
SCHEMBL19433069 0.87 DOT1L (0.82) AHCYNADKDOT1LDNMT3BCARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10183965-B2 Cofactor analogues for methyltransferases KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2019-01-22 US disclosed
US-20170283453-A1 COFACTOR ANALOGUES FOR METHYLTRANSFERASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2017-10-05 US disclosed
EP-3186266-A1 S-ADENOSYL-L-CYSTEINE ANALOGUES AS COFACTORS FOR METHYLTRANSFERASES Katholieke Universiteit Leuven (BE) 2017-07-05 EP disclosed
WO-2016030546-A1 S-ADENOSYL-L-CYSTEINE ANALOGUES AS COFACTORS FOR METHYLTRANSFERASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10183965-B2 Cofactor analogues for methyltransferases BHMT, BHMT2, NNMT AHCY 10/4885NADK 163/4885DOT1L 44/4885
US-20170283453-A1 COFACTOR ANALOGUES FOR METHYLTRANSFERASES BHMT, BHMT2, NNMT AHCY 10/4885NADK 163/4885DOT1L 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.